The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Implantable transvenous cardioverter-defibrillators.
Abstract
BACKGROUND: Implantable transvenous cardioverter-defibrillators offer a significant opportunity to decrease procedural morbidity and medical costs in the care of patients with life-threatening ventricular arrhythmias who otherwise would have required a sternotomy or thoracotomy for device insertion. The purpose of this study was to examine prospectively the safety, efficacy, and limitations associated with the use of a transvenously implanted, tiered-therapy cardioverter-defibrillator with antitachycardia pacing function in a consecutive population of 84 ventricular fibrillation (VF) and sustained ventricular tachycardia (VT) survivors. METHODS AND RESULTS: The index arrhythmia promoting transvenous cardioverter-defibrillator implantation was VF in 41 patients, VT in 27, and both VF and VT in 16. In each patient, transvenous defibrillation via a coronary sinus, a right ventricular, a superior vena caval, and/or a subcutaneous chest patch lead system was attempted. The pulsing methods used include two-electrode single-pathway pulsing or three-electrode dual-pathway simultaneous or sequential pulsing. A transvenous cardioverter-defibrillator was inserted if the defibrillation threshold (DFT) was < or = 20 J. Successful implantation of a transvenous cardioverter-defibrillator was possible in 80 of 84 (95%) patients. The mean implant DFT was 10.9 +/- 4.8 J. After cardioverter-defibrillator implantation, all patients were extubated in the operating room and sent to a standard telemetry ward for monitoring. No patient suffered a postoperative pulmonary complication or perioperative flurry of cardiac arrhythmias. Postoperative complications included lead dislodgments in eight, transient long thoracic nerve injury in one, asymptomatic left subclavian vein occlusion in two, asymptomatic small pericardial effusion in one, subcutaneous patch pocket hematomas in four, pulse generator pocket infection in one, and lead fracture in one. As experience was gained with the procedure, it was routine to discharge patients 3 days after surgery. The mean hospital stay was 6.0 +/- 2.4 days. Upon discharge, all patients returned to their prehospital activities including those with complications except for the patient with a pocket infection, who required intravenous antibiotic therapy. Patient survival using an intention-to-treat analysis was 98% over an 11 +/- 7-month follow-up period. During this time period, 31 of the 80 patients (39%) with transvenous lead systems were successfully treated by their device for sustained VT or VF. Antitachycardia pacing was used in 424 episodes of monomorphic VT and was successful in 371 (88%). All episodes of VF were aborted by the device. Antiarrhythmic drugs were used after device implantation in only eight of 80 patients (10%). CONCLUSIONS: Transvenous cardioverter-defibrillator implantation is practical in most candidates. Implant DFTs are usually low, surgical morbidity and postoperative complications are modest, therapy of VT and VF is efficient, and survival is excellent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term outcome with the automatic implantable cardioverter-defibrillator
Winkle, R. A., Mead, R. H., Ruder, M. A., Gaudiani, V. A., Smith, N. A., Buch, W. S., Schmidt, P., & Shipman, T. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90310-0 · Cited by 719
Kelly, P. A., Cannom, D. S., Garan, H., Mirabal, G. S., Harthorne, J. W., Hurvitz, R. J., Vlahakes, G. J., Jacobs, M. L., Ilvento, J. P., Buckley, M. J., et al. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90292-6 · Cited by 380
Antiarrhythmic Drugs: a Possible Cause of Out-of-Hospital Cardiac Arrest
Ruskin, J. N., McGovern, B., Garan, H., DiMarco, J. P., & Kelly, E. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311243092107 · Cited by 227
Fogoros, R. N., ELSON, J. J., BONNET, C. A., FIEDLER, S. B., & Burkholder, J. A. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90590-l · Cited by 212
Morady, F., Kadish, A., Rosenheck, S., Calkins, H., Kou, W. H., De Buitleir, M., & Sousa, J. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80184-6 · Cited by 190
Larsen, G. C., Manolis, A. S., Sonnenberg, F. A., Beshansky, J. R., Estes, N. A. M., & Pauker, S. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90341-j · Cited by 108
Cardiac pacing and pacemakers IV. Threshold of cardiac stimulation
Furman, S., Hurzeler, P., & Mehra, R. (1977) · American Heart Journal · doi:10.1016/s0002-8703(77)80353-0 · Cited by 82
Kim, S. G., Fisher, J. D., Furman, S., GROSS, J. N., Zilo, P., Roth, J. A., Ferrick, K. J., & Brodman, R. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90536-i · Cited by 42
Bardy, G. H., Ivey, T. D., Allen, M. D., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90311-2 · Cited by 36
Self-citationPharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial
Morganroth, J., & Bigger, J. T. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91362-a · Cited by 34
Cited by
Kuck, K.-H., Cappato, R., Siebels, J., & Rüppel, R. (2000) · Circulation · doi:10.1161/01.cir.102.7.748 · Cited by 1,482
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori, S. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2824 · Cited by 903
Sudden death in Chagas' disease
Rassi Jr, A., Rassi, S. G., & Rassi, A. (2001) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2001000100008 · Cited by 282
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
ALTER, P., WALDHANS, S., PLACHTA, E., MOOSDORF, R., & GRIMM, W. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00195.x · Cited by 274
Long-Term Follow-Up of Idiopathic Ventricular Fibrillation Ablation
Knecht, S., Sacher, F., Wright, M., Hocini, M., Nogami, A., Arentz, T., Petit, B., Franck, R., De Chillou, C., Lamaison, D., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.065 · Cited by 265
Metadata
- Authors
- Bardy, G. H., Hofer, B., Johnson, G., Kudenchuk, P. J., Poole, J. E., Dolack, G. L., Gleva, M., Mitchell, R., & Kelso, D.
- Venue
- Circulation
- Published
- 1993-04
- Volume
- 87
- Issue
- 4
- Pages
- 1152-1168
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2123046915
- Cited by
- 273
- References
- 10
- FWCI
- 41.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implantable transvenous cardioverter-defibrillators. https://app.cochat.ai/papers/10.1161/01.cir.87.4.1152
- The paper
- Bardy, G. H., Hofer, B., Johnson, G., Kudenchuk, P. J., Poole, J. E., Dolack, G. L., Gleva, M., Mitchell, R., & Kelso, D. (1993). Implantable transvenous cardioverter-defibrillators. Circulation. https://doi.org/10.1161/01.cir.87.4.1152
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.